Medications

Botox developer rues missing out on billions

Botox developer Alan Scott says he rues the day he handed over rights to the best-selling wrinkle-smoothing drug to a US company for just $4.5 million, saying he might have become a billionaire.

Medications

Pot-based prescription drug looks for FDA OK

A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in marijuana, additional medicines derived from or inspired by the cannabis plant ...

Other

Botulinum toxin does not cure common forms of neck pain

There is no evidence that Botulinum toxin injections reduce chronic neck pain or associated headaches, says a group of scientists who reviewed nine trials involving a total of 503 participants. Their findings are published ...

Diseases, Conditions, Syndromes

Managing multiple sclerosis

Multiple sclerosis (MS) is a disease that looks different in everyone who has it—and you may know more people who have it than you think.

Medications

First cannabis-derived drug authorised for France

France has for the first time approved prescription use of a drug derived from cannabis—a mouth spray used to treat multiple sclerosis (MS) symptoms, the government said Thursday.

page 5 from 7